U.S. Senator Warren 'particularly Concerned' About Amgen, Indivior Deals

U.S. Senator Warren ‘particularly Concerned’ About Amgen, Indivior Deals

WASHINGTON (Reuters) -Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals. In a letter dated Wednesday, Warren said that she was focused on Amgen’s plan to buy Horizon Therapeutics, and addiction specialist Indivior’s plan to buy Opiant for $145 million,…

Read More
U.S. Watchdog Should Step Up Oversight Of Crypto Auditors, Say Democratic Senators

U.S. Watchdog Should Step Up Oversight Of Crypto Auditors, Say Democratic Senators

By Hannah Lang and Douglas Gillison (Reuters) – U.S. Democratic Senators Elizabeth Warren and Ron Wyden are calling on the country’s accounting watchdog to increase oversight of firms that audit cryptocurrency companies in the wake of the collapse of crypto exchange FTX. In a letter to the U.S. Public Company Accounting Oversight Board (PCAOB) made…

Read More
Warren Tells FTC She Is "particularly Concerned" About Amgen And Indivior Deals

Warren Tells FTC She Is “particularly Concerned” About Amgen And Indivior Deals

WASHINGTON (Reuters) – Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals. In a letter dated Wednesday, Warren said that she was focused on Amgen’s plan to buy Horizon Therapeutics, and addiction specialist Indivior’s plan to buy Opiant for $145…

Read More